CoChat
Sign Up
Cited by 138

Estrogen Regulation of MicroRNA Expression

Klinge, Carolyn·2009·Current Genomics
DOI 10.2174/138920209788185289PMC PMC2705850
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/138920209788185289

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Three out of eight female-dominant miRNAs: mir-182, mir-148a, and mir-145a, were also shown previously to be estrogen regulated.

    “Three out of eight female-dominant miRNAs: mir-182, mir-148a, and mir-145a, were also shown previously to be estrogen regulated (59)”

    From A mouse tissue atlas of small noncoding RNA (2020) · cites this paper as [59]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 228

  1. [1]Vina J Sastre J Pallardo FV Gambini J Borras C Modulation of longevity-associated genes by estrogens or phytoestrogens Biol. Chem 2008 389 273 277 18177268
  2. [2]Wise PM Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models Neuroscience 2006 138 831 835 16310320
  3. [3]Wynne FL Payne JA Cain AE Reckelhoff JF Khalil RA Age-related reduction in estrogen receptor-mediated mechanisms of vascular relaxation in female spontaneously hypertensive rats Hypertension 2004 43 405 412 14699001
  4. [4]Moolman JA Unravelling the cardioprotective mechanism of action of estrogens Cardiovasc. Res 2006 69 777 780 16532550
  5. [5]Alonso A Moreno M Ordonez P Fernandez R Perez C Diaz F Navarro A Tolivia J Gonzalez C Chronic estradiol treatment improves brain homeostasis during aging in female rats Endocrinology 2008 149 57 72 17901235
  6. [6]Lamberts SW van den Beld AW van der Lely AJ The endocrinology of aging Science 1997 278 419 424 9334293
  7. [7]Casadesus G Rolston RK Webber KM Atwood CS Bowen RL Perry G Smith MA Menopause, estrogen, and gonadotropins in alzheimer's disease Adv. Clin. Chem 2008 45 139 153 18429496
  8. [8]Worzala K Hiller R Sperduto RD Mutalik K Murabito JM Moskowitz M D'Agostino RB Wilson PWF Postmenopausal estrogen use, type of menopause, and lens opacities: the framingham studies Arch. Intern. Med 2001 161 1448 1454 11386895
  9. [9]Zamore PD Haley B Ribo-gnome: the big world of small rnas Science 2005 309 1519 1524 16141061
  10. [10]Zeng Y Principles of micro-rna production and maturation Oncogene 2006 25 6156 6162 17028594
  11. [11]Couzin J Genetics.Erasing microRNAs reveals their powerful punch Science 2007 316 530 17463259
  12. [12]Blenkiron C Goldstein LD Thorne NP Spiteri I Chin SF Dunning MJ Barbosa-Morais NL Teschendorff AE Green AR Ellis IO Tavare S Caldas C Miska EA Microrna expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biol 2007 8 R214 17922911 PMC2246288
  13. [13]Si ML Zhu S Wu H Lu Z Wu F Mo YY Mir-21-mediated tumor growth Oncogene 2007 26 2799 2803 17072344
  14. [14]Adams BD Claffey KP White BA Argonaute-2 expression is regulated by EGFR/MAPK signaling and correlates with a transformed phenotype in breast cancer cells Endocrinology 2009 150 1 14 23 18787018 PMC2630894
  15. [15]Foekens JA Sieuwerts AM Smid M Look MP de Weerd V Boersma AWM Klijn JGM Wiemer EAC Martens JWM Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer Proc. Natl. Acad. Sci. USA 2008 105 13021 13026 18755890 PMC2529088
  16. [16]Lowery AJ Miller N McNeill RE Kerin MJ MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management Clin. Cancer Res 2008 14 360 365 18223209
  17. [17]Miller TE Ghoshal K Ramaswamy B Roy S Datta J Shapiro CL Jacob S Majumder S MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27(kip1) J. Biol. Chem 2008 283 29897 29903 18708351 PMC2573063
  18. [18]Tavazoie SF Alarcon C Oskarsson T Padua D Wang Q Bos PD Gerald WL Massague J Endogenous human microRNAs that suppress breast cancer metastasis Nature 2008 451 147 152 18185580 PMC2782491
  19. [19]Yu Z Wang C Wang M Li Z Casimiro MC Liu M Wu K Whittle J Ju X Hyslop T McCue P Pestell RG A cyclin d1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J. Cell Biol 2008 182 509 517 18695042 PMC2500136
  20. [20]Iorio MV Ferracin M Liu C-G Veronese A Spizzo R Sabbioni S Magri E Pedriali M Fabbri M Campiglio M Menard S Palazzo JP Rosenberg A Musiani P Volinia S Nenci I Calin GA Querzoli P Negrini M Croce CM MicroRNA gene expression deregulation in human breast cancer Cancer Res 2005 65 7065 7070 16103053
  21. [21]Jiang J Lee EJ Gusev Y Schmittgen TD Real-time expression profiling of microRNA precursors in human cancer cell lines Nucleic Acids Res 2005 33 5394 5403 16192569 PMC1236977
  22. [22]Mattie MD Benz CC Bowers J Sensinger K Wong L Scott GK Fedele V Ginzinger D Getts R Haqq C Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies Mol. Cancer 2006 5 24 16784538 PMC1563474
  23. [23]Maglich JM Sluder A Guan X Shi Y McKee DD Carrick K Kamdar K Willson TM Moore JT Comparison of complete nuclear receptor sets from the human, caenorhabditis elegans and drosophila genomes Genome Biol 2001 2 RESEARCH0029 PMC55326 11532213
  24. [24]Klinge CM Estrogen receptor interaction with estrogen response elements Nucleic Acids Res 2001 29 2905 2919 11452016 PMC55815
  25. [25]Thornton JW Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions Proc. Natl. Acad. Sci. USA 2001 98 5671 5676 11331759 PMC33271
  26. [26]Thornton JW Need E Crews D Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling Science 2003 301 1714 1717 14500980
  27. [27]Tanenbaum DM Wang Y Williams SP Sigler PB Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains Proc. Natl. Acad. Sci. USA 1998 95 5998 6003 9600906 PMC27574
  28. [28]Metivier R Stark A Flouriot G Hubner MR Brand H Penot G Manu D Denger S Reid G Kos M Russell RB Kah O Pakdel F Gannon F A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant a and e domains Mol. Cell 2002 10 1019 1032 12453411
  29. [29]Ruff M Gangloff M Wurtz JM Moras D Estrogen receptor transcription and transactivation: structure-function relationship in DNA- and ligand-binding domains of estrogen receptors Breast Cancer Res 2000 2 353 359 11250728 PMC138657
  30. [30]Carroll JS Meyer CA Song J Li W Geistlinger TR Eeckhoute J Brodsky AS Keeton EK Fertuck KC Hall GF Wang Q Bekiranov S Sementchenko V Fox EA Silver PA Gingeras TR Liu XS Brown M Genome-wide analysis of estrogen receptor binding sites Nat. Genet 2006 38 1289 1297 17013392
  31. [31]Carroll JS Brown M Estrogen receptor target gene: an evolving concept Mol. Endocrinol 2006 20 1707 1714 16396959
  32. [32]Liu Y Gao H Marstrand TT Strom A Valen E Sandelin A Gustafsson J-A Dahlman-Wright K The genome landscape of er{alpha}- and er{beta}-binding DNA regions Proceedings of the National Academy of Sciences 2008 0712085105 PMC2268183 18272478
  33. [33]Lin CY Vega VB Thomsen JS Zhang T Kong SL Xie M Chiu KP Lipovich L Barnett DH Stossi F Yeo A George J Kuznetsov VA Lee YK Charn TH Palanisamy N Miller LD Cheung E Katzenellenbogen BS Ruan Y Bourque G Wei CL Liu ET Whole-genome cartography of estrogen receptor alpha binding sites PLoS Genet 2007 3 e87 17542648 PMC1885282
  34. [34]Kwon Y-S Garcia-Bassets I Hutt KR Cheng CS Jin M Liu D Benner C Wang D Ye Z Bibikova M Fan J-B Duan L Glass CK Rosenfeld MG Fu X-D Sensitive chip-dsl technology reveals an extensive estrogen receptor {alpha}-binding program on human gene promoters Proc. Natl. Acad. Sci. USA 2007 104 4852 4857 17360330 PMC1821125
  35. [35]McKenna NJ Lanz RB O'Malley BW Nuclear receptor coregulators: Cellular and molecular biology Endocr. Rev 1999 20 321 344 10368774
  36. [36]Bourdeau V Deschenes J Laperriere D Aid M White JH Mader S Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells Nucleic Acids Res 2008 36 76 93 17986456 PMC2248750
  37. [37]Lannigan DA Estrogen receptor phosphorylation Steroids 2003 68 1 9 12475718
  38. [38]Stenoien DL Mancini MG Patel K Allegretto EA Smith CL Mancini MA Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1 Mol. Endocrinol 2000 14 518 534 10770489
  39. [39]Stenoien DL Nye AC Mancini MG Patel K Dutertre M O'Malley BW Smith CL Belmont AS Mancini MA Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells Mol. Cell. Biol 2001 21 4404 4412 11390668 PMC87100
  40. [40]Stenoien DL Patel K Mancini MG Dutertre M Smith CL O'Malley BW Mancini MA Frap reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent Nat. Cell. Biol 2001 3 15 23 11146621
  41. [41]Porter W Wang F Wang W Duan R Safe S Role of estrogen receptor/sp1 complexes in estrogen-induced heat shock protein 27 gene expression Mol. Endocrinol 1996 10 1371 1378 8923463
  42. [42]Paech K Webb P Kuiper GG Nilsson S Gustafsson J Kushner PJ Scanlan TS Differential ligand activation of estrogen receptors eralpha and erbeta at ap1 sites Science 1997 277 1508 1510 9278514
  43. [43]Klinge CM Estrogen receptor interaction with co-activators and co-repressors Steroids 2000 65 227 251 10751636
  44. [44]Lonard DM O'Malley BW Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation Mol. Cell 2007 27 691 700 17803935
  45. [46]Horwitz K Jackson T Bain D Richer J Takimoto G Tung L Nuclear receptor coactivators and corepressors Mol. Endocrinol 1996 10 1167 1177 9121485
  46. [47]O'Malley BW McKenna NJ Editorial: coactivators and corepressors: what's in a name? Mol. Endocrinol 2008 22 2213 2214 18701638 PMC2582534
  47. [48]Peterson TJ Karmakar S Pace MC Gao T Smith CL The silencing mediator of retinoic acid and thyroid hormone receptor (smrt) corepressor is required for full estrogen receptor {alpha} transcriptional activity Mol. Cell. Biol 2007 27 5933 5948 17591692 PMC1952168
  48. [49]Yang XJ Seto E Hats and hdacs: from structure, function and regulation to novel strategies for therapy and prevention Oncogene 2007 26 5310 5318 17694074
  49. [50]Privalsky ML The role of corepressors in transcriptional regulation by nuclear hormone receptors Annu. Rev. Physiol 2004 66 315 360 14977406
  50. [51]Smith CL O'Malley BW Coregulator function: a key to understanding tissue specificity of selective receptor modulators Endocr. Rev 2004 25 45 71 14769827
  51. [52]Beato M Candau R Chavez S Mows C Truss M Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling J. Steroid Biochem. Mol. Biol 1996 56 47 59 8603047
  52. [53]Shiau AK Barstad D Loria PM Cheng L Kushner PJ Agard DA Greene GL The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 1998 95 927 937 9875847
  53. [54]Smith CL Nawaz Z O'Malley BW Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen Mol. Endocrinol 1997 11 657 666 9171229
  54. [55]Shang Y Hu X DiRenzo J Lazar MA Brown M Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 2000 103 843 852 11136970
  55. [56]Jung DJ Lee SK Lee JW Agonist-dependent repression mediated by mutant estrogen receptor alpha that lacks the activation function 2 core domain J. Biol. Chem 2001 276 37280 37283 11487586
  56. [57]Shang Y Brown M Molecular determinants for the tissue specificity of serms Science 2002 295 2465 2468 11923541
  57. [58]Huang HJ Norris JD McDonnell DP Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists Mol. Endocrinol 2002 16 1778 1792 12145334
  58. [59]Wijayaratne AL Nagel SC Paige LA Christensen DJ Norris JD Fowlkes DM McDonnell DP Comparative analyses of mechanistic differences among antiestrogens Endocrinology 1999 140 5828 5840 10579349
  59. [60]Peekhaus N Chang T Hayes E Wilkinson H Mitra S Schaeffer J Rohrer S Distinct effects of the antiestrogen faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line mcf-7 J. Mol. Endocrinol 2004 32 987 995 15171727
  60. [61]Chambliss KL Shaul PW Estrogen modulation of endothelial nitric oxide synthase Endocr. Rev 2002 23 665 686 12372846
  61. [62]Pedram A Razandi M Levin ER Nature of functional estrogen receptors at the plasma membrane Mol. Endocrinol 2006 20 1996 2009 16645038
  62. [63]Kim JK Levin ER Estrogen signaling in the cardiovascular system Nucleic Recept. Signal 2006 4 e013 PMC1513067 16862219
  63. [64]Levin ER Integration of the extranuclear and nuclear actions of estrogen Mol. Endocrinol 2005 19 1951 1959 15705661 PMC1249516
  64. [65]Watson CS Alyea RA Jeng YJ Kochukov MY Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues Mol. Cell. Endocrinol 2007 274 1 7 17601655 PMC1986712
  65. [66]Razandi M Pedram A Levin ER Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer Mol. Endocrinol 2000 14 1434 1447 10976921
  66. [67]Hisamoto K Ohmichi M Kurachi H Hayakawa J Kanda Y Nishio Y Adachi K Tasaka K Miyoshi E Fujiwara N Taniguchi N Murata Y Estrogen induces the akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells J. Biol. Chem 2001 276 3459 3467 11044445
  67. [68]Monje P Boland R Expression and cellular localization of naturally occurring beta estrogen receptors in uterine and mammary cell lines J. Cell. Biochem 2002 86 136 144 12112024
  68. [69]Chen DB Bird IM Zheng J Magness RR Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells Endocrinology 2004 145 113 125 14512434
  69. [70]Belcher SM Le HH Spurling L Wong JK Rapid estrogenic regulation of extracellular signal- regulated kinase 1/2 signaling in cerebellar granule cells involves a g protein- and protein kinase a-dependent mechanism and intracellular activation of protein phosphatase 2a Endocrinology 2005 146 5397 5406 16123167
  70. [71]Mhyre AJ Shapiro RA Dorsa DM Estradiol reduces non-classical transcription at cyclic adenosine 3',5'-monophosphate response elements in glioma cells expressing estrogen receptor alpha Endocrinology 2006 147 1796 1804 16439453
  71. [72]Simoncini T Scorticati C Mannella P Fadiel A Giretti MS Fu X-D Baldacci C Garibaldi S Caruso A Fornari L Naftolin F Genazzani AR Estrogen receptor {alpha} interacts with g{alpha}13 to drive actin remodeling and endothelial cell migration via the rhoa/rho kinase/moesin pathway Mol. Endocrinol 2006 20 1756 1771 16601072
  72. [73]Filardo E Quinn J Pang Y Graeber C Shaw S Dong J Thomas P Activation of the novel estrogen receptor g protein-coupled receptor 30 (gpr30) at the plasma membrane Endocrinology 2007 148 3236 3245 17379646
  73. [74]Jaubert A-M Mehebik-Mojaat N Lacasa D Sabourault D Giudicelli Y Ribiere C Nongenomic estrogen effects on nitric oxide synthase activity in rat adipocytes Endocrinology 2007 148 2444 2452 17303666
  74. [75]Wang C Prossnitz ER Roy SK G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary Endocrinology 2008 149 4452 4461 18499747 PMC2553386
  75. [76]Graber R Sumida C Vallette G Nunez EA Rapid and long-term effects of 17 beta-estradiol on pip2-phospholipase c-specific activity of mcf-7 cells Cell Signal 1993 5 181 186 8388702
  76. [77]Improta-Brears T Whorton AR Codazzi F York JD Meyer T McDonnell DP Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium Proc. Natl. Acad. Sci. USA 1999 96 4686 4691 10200323 PMC16393
  77. [78]Levin ER Cellular functions of plasma membrane estrogen receptors Steroids 2002 67 471 475 11960623
  78. [79]Razandi M Oh P Pedram A Schnitzer J Levin ER Ers associate with and regulate the production of caveolin: Implications for signaling and cellular actions Mol. Endocrinol 2002 16 100 115 11773442
  79. [80]Song RX-D McPherson RA Adam L Bao Y Shupnik M Kumar R Santen RJ Linkage of rapid estrogen action to mapk activation by er{alpha}-shc association and shc pathway activation Mol. Endocrinol 2002 16 116 127 11773443
  80. [81]Razandi M Alton G Pedram A Ghonshani S Webb P Levin ER Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane Mol. Cell. Biol 2003 23 1633 1646 12588983 PMC151696
  81. [82]Razandi M Pedram A Park ST Levin ER Proximal events in signaling by plasma membrane estrogen receptors J. Biol. Chem 2003 278 2701 2712 12421825
  82. [83]Bulayeva NN Gametchu B Watson CS Quantitative measurement of estrogen-induced erk 1 and 2 activation via multiple membrane-initiated signaling pathways Steroids 2004 69 181 192 15072920 PMC1201430
  83. [84]Fernando RI Wimalasena J Estradiol abrogates apoptosis in breast cancer cells through inactivation of bad: ras-dependent nongenomic pathways requiring signaling through erk and akt Mol. Biol. Cell 2004 15 3266 3284 15121878 PMC452582
  84. [85]Razandi M Pedram A Merchenthaler I Greene GL Levin ER Plasma membrane estrogen receptors exist and functions as dimers Mol. Endocrinol 2004 18 2854 2865 15231873
  85. [86]Razandi M Pedram A Rosen EM Levin ER Brca1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer Mol. Cell. Biol 2004 24 5900 5913 15199145 PMC480898
  86. [87]Santen RJ Song RX Zhang Z Yue W Kumar R Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer Clin. Cancer Res 2004 10 337S 345S 14734489
  87. [88]Simoncini T Mannella P Fornari L Caruso A Willis MY Garibaldi S Baldacci C Genazzani AR Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells Endocrinology 2004 145 5745 5756 15358673
  88. [89]Song RX Barnes CJ Zhang Z Bao Y Kumar R Santen RJ The role of shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor {alpha} to the plasma membrane Proc. Natl. Acad Sci. USA 2004 101 2076 2081 14764897 PMC357054
  89. [90]Toran-Allerand CD Minireview: a plethora of estrogen receptors in the brain: Where will it end? Endocrinology 2004 145 1069 1074 14670986
  90. [91]Pietras RJ Marquez DC Chen HW Tsai E Weinberg O Fishbein M Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells Steroids 2005 70 372 381 15862820
  91. [92]Watson CS Bulayeva NN Wozniak AL Finnerty CC Signaling from the membrane via membrane estrogen receptor-[alpha]: Estrogens, xenoestrogens, and phytoestrogens Steroids 2005 70 364 371 15862819
  92. [93]Cui Y Parra I Zhang M Hilsenbeck SG Tsimelzon A Furukawa T Horii A Zhang Z-Y Nicholson RI Fuqua SAW Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance Cancer Res 2006 66 5950 5959 16740736 PMC4484848
  93. [94]Riggins RB Thomas KS Ta HQ Wen J Davis RJ Schuh NR Donelan SS Owen KA Gibson MA Shupnik MA Silva CM Parsons SJ Clarke R Bouton AH Physical and functional interactions between cas and c-src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b Cancer Res 2006 66 7007 7015 16849545
  94. [95]Greger JG Fursov N Cooch N McLarney S Freedman LP Edwards DP Cheskis BJ Phosphorylation of mnar promotes estrogen activation of phosphatidylinositol 3-kinase Mol. Cell. Biol 2007 27 1904 1913 17194752 PMC1820473
  95. [96]Song RXD Zhang Z Chen Y Bao Y Santen RJ Estrogen signaling via a linear pathway involving insulin-like growth factor i receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in mcf-7 breast cancer cells Endocrinology 2007 148 4091 4101 17525128 PMC2727866
  96. [97]Stoica GE Franke TF Wellstein A Czubayko F List HJ Reiter R Morgan E Martin MB Stoica A Estradiol rapidly activates akt via the erbb2 signaling pathway Mol. Endocrinol 2003 17 818 830 12554767
  97. [98]Rajhans R Nair S Holden AH Kumar R Tekmal RR Vadlamudi RK Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor Cancer Res 2007 67 5505 5512 17545633 PMC2774841
  98. [99]Ghisletti S Meda C Maggi A Vegeto E 17{beta}-estradiol inhibits inflammatory gene expression by controlling nf-{kappa}b intracellular localization Mol. Cell. Biol 2005 25 2957 2968 15798185 PMC1069609
  99. [100]Lu Q Pallas DC Surks HK Baur WE Mendelsohn ME Karas RH Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial no synthase by estrogen receptor {alpha} Proc. Natl. Acad Sci. USA 2004 0407492101 PMC534607 15569929
  100. [101]Sun M Yang L Feldman RI Sun XM Bhalla KN Jove R Nicosia SV Cheng JQ Activation of phosphatidylinositol 3-kinase/akt pathway by androgen through interaction of p85alpha, androgen receptor, and src J. Biol. Chem 2003 278 42992 43000 12933816
  101. [102]Kinoshita Y Chen S Induction of aromatase (cyp19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha Cancer Res 2003 63 3546 3555 12839940
  102. [103]Pietras RJ Szego CM Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells Nature 1977 265 69 72 834244
  103. [104]Watson CS Campbell CH Gametchu B The dynamic and elusive membrane estrogen receptor-alpha Steroids 2002 67 429 437 11960618
  104. [105]Sheldahl LC Shapiro RA Bryant DN Koerner IP Dorsa DM Estrogen induces rapid translocation of estrogen receptor [beta], but not estrogen receptor [alpha], to the neuronal plasma membrane Neuroscience 2008 153 751 761 18406537 PMC2587260
  105. [106]Murphy E Steenbergen C Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury Cardiovasc. Res 2007 75 478 486 17466956
  106. [107]Murphy E Steenbergen C Cardioprotection in females: a role for nitric oxide and altered gene expression Heart Fail Rev 2007 12 293 300 17508281
  107. [108]Subah Packer C Estrogen protection, oxidized ldl, endothelial dysfunction and vasorelaxation in cardiovascular disease: New insights into a complex issue Cardiovasc. Res 2007 73 6 7 17156767
  108. [109]Joy S Siow RCM Rowlands DJ Becker M Wyatt AW Aaronson PI Coen CW Kallo I Jacob R Mann GE The isoflavone equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/hsp90 involving erk1/2 and akt phosphorylation in human endothelial cells J. Biol. Chem 2006 281 27335 27345 16840783
  109. [110]Kiss AL Turi A Mullner N Kovacs E Botos E Greger A Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: an in vivo study Mol. Cell. Endocrinol 2005 245 128 137 16368181
  110. [111]Wyckoff MH Chambliss KL Mineo C Yuhanna IS Mendelsohn ME Mumby SM Shaul PW Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through galpha(i) J. Biol. Chem 2001 276 27071 27076 11369763
  111. [112]Li L Haynes MP Bender JR Plasma membrane localization and function of the estrogen receptor alpha variant (er46) in human endothelial cells Proc. Natl. Acad. Sci. USA 2003 100 4807 4812 12682286 PMC153637
  112. [113]Acconcia F Ascenzi P Fabozzi G Visca P Marino M Spalmitoylation modulates human estrogen receptor-alpha functions Biochem. Biophys. Res. Commun 2004 316 878 883 15033483
  113. [114]Pedram A Razandi M Sainson RCA Kim JK Hughes CC Levin ER A conserved mechanism for steroid receptor translocation to the plasma membrane J. Biol. Chem 2007 282 22278 22288 17535799
  114. [115]Moriarty K Kim KH Bender JR Estrogen receptor-mediated rapid signaling Endocrinology 2006 147 5557 5563 16946015
  115. [116]Wong CW McNally C Nickbarg E Komm BS Cheskis BJ Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with src/erk phosphorylation cascade Proc. Natl. Acad. Sci. USA 2002 99 14783 14788 12415108 PMC137496
  116. [117]Edwards DP Boonyaratanakornkit V Rapid extranuclear signaling by the estrogen receptor (er): Mnar couples er and src to the map kinase signaling pathway Mol. Interv 2003 3 12 15 14993433
  117. [118]Barletta F Wong CW McNally C Komm BS Katzenellen-bogen B Cheskis BJ Characterization of the interactions of estrogen receptor and mnar in the activation of csrc Mol. Endocrinol 2004 18 1096 1108 14963108
  118. [119]Cheskis BJ Regulation of cell signalling cascades by steroid hormones J. Cell Biochem 2004 93 20 27 15352158
  119. [120]Mishra SK Balasenthil S Nguyen D Vadlamudi RK Cloning and functional characterization of pelp1/mnar promoter Gene 2004 330 115 122 15087130
  120. [121]Mishra SK Talukder AH Gururaj AE Yang Z Singh RR Mahoney MG Franci C Vadlamudi RK Kumar R Upstream determinants of estrogen receptor-{alpha} regulation of metastatic tumor antigen 3 pathway J. Biol. Chem 2004 279 32709 32715 15169784 PMC1262658
  121. [122]Nair SS Mishra SK Yang Z Balasenthil S Kumar R Vadlamudi RK Potential role of a novel transcriptional coactivator pelp1 in histone h1 displacement in cancer cells Cancer Res 2004 64 6416 6423 15374949
  122. [123]Kim KH Bender JR Rapid, estrogen receptor-mediated signaling: Why is the endothelium so special? Sci. STKE 2005 2005 pe28 15956360
  123. [124]Greger JG Guo Y Henderson R Ross JF Cheskis BJ Characterization of mnar expression Steroids 2006 71 317 322 16297421
  124. [125]Li L Hisamoto K Kim KH Haynes MP Bauer PM San-jay A Collinge M Baron R Sessa WC Bender JR Variant estrogen receptor c-src molecular interdependence and c-src structural requirements for endothelial no synthase activation Proc. Natl. Acad. Sci 2007 104 16468 16473 17921256 PMC2034248
  125. [126]Marquez-Garban DC Chen H-W Fishbein MC Goodglick L Pietras RJ Estrogen receptor signaling pathways in human non-small cell lung cancer Steroids 2007 72 135 143 17276470 PMC6662925
  126. [127]Cheskis BJ Greger J Cooch N McNally C McLarney S Lam H-S Rutledge S Mekonnen B Hauze D Nagpal S Freedman LP Mnar plays an important role in era activation of Src/MAPK and pi3k/Akt signaling pathways Steroids 2008 73 9-10 901 905 18261753
  127. [128]Rajhans R Nair HB Nair SS Cortez V Ikuko K Kirma NB Zhou D Holden AE Brann DW Chen S Tekmal RR Vadlamudi RK Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: Potential estrogen receptor autocrine signaling loop in breast cancer cells Mol. Endocrinol 2008 22 649 664 18079323 PMC2262166
  128. [129]Hisamoto K Bender JR Vascular cell signaling by membrane estrogen receptors Steroids 2005 70 382 387 15862821
  129. [130]Flototto T Niederacher D Hohmann D Heimerzheim T Dall P Djahansouzi S Bender HG Hanstein B Molecular mechanism of estrogen receptor (er)[alpha]-specific, estradiol-dependent expression of the progesterone receptor (pr) b-isoform J. Steroid Biochem. Mol. Biol 2004 88 131 142 15084345
  130. [131]Filardo EJ Epidermal growth factor receptor (egfr) transactivation by estrogen via the g-protein-coupled receptor, gpr30: a novel signaling pathway with potential significance for breast cancer J. Steroid Biochem. Mol. Biol 2002 80 231 238 11897506
  131. [132]Revankar CM Cimino DF Sklar LA Arterburn JB Prossnitz ER A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 2005 307 1625 1630 15705806
  132. [133]Thomas P Pang Y Filardo EJ Dong J Identity of an estrogen membrane receptor coupled to a g protein in human breast cancer cells Endocrinology 2005 146 624 632 15539556
  133. [134]Funakoshi T Yanai A Shinoda K Kawano MM Mizukami Y G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane Biochem. Biophys. Res. Commun 2006 346 904 910 16780796
  134. [135]Wang C Dehghani B Magrisso IJ Rick EA Bonhomme E Cody DB Elenich LA Subramanian S Murphy SJ Kelly MJ Rosenbaum JS Vandenbark AA Offner H Gpr30 contributes to estrogen-induced thymic atrophy Mol. Endocrinol 2008 22 636 648 18063692 PMC2262170
  135. [136]Prossnitz ER Oprea TI Sklar LA Arterburn JB The ins and outs of gpr30: a transmembrane estrogen receptor J. Steroid Biochem. Mol. Biol 2008 109 350 353 18406603 PMC2481563
  136. [137]Otto C Rohde-Schulz B Schwarz G Fuchs I Klewer M Brittain D Langer G Bader B Prelle K Nubbemeyer R Fritzemeier K-H Gpr30 localizes to the endoplasmic reticulum and is not activated by estradiol Endocrinology 2008 149 10 4846 4856 18566127
  137. [138]Filardo EJ Quinn JA Sabo E Association of the membrane estrogen receptor, gpr30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor Steroids 2008 73 870 873 18289622
  138. [139]Sakamoto H Matsuda K-i Hosokawa K Nishi M Morris JF Prossnitz ER Kawata M Expression of g protein-coupled receptor-30, a g protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei Endocrinology 2007 148 5842 5850 17872373
  139. [140]Thomas P Dong J Binding and activation of the seven-transmembrane estrogen receptor gpr30 by environmental estrogens: a potential novel mechanism of endocrine disruption J. Steroid Biochem. Mol. Biol 2006 102 175 179 17088055
  140. [141]Filardo EJ Graeber CT Quinn JA Resnick MB Giri D DeLellis RA Steinhoff MM Sabo E Distribution of gpr30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression Clin. Cancer Res 2006 12 6359 6366 17085646
  141. [142]ENCODE, project, consortium. Identification and analysis of functional elements in 1% of the human genome by the encode pilot project Nature 2007 447 799 816 17571346 PMC2212820
  142. [143]Kapranov P Cheng J Dike S Nix DA Duttagupta R Willingham AT Stadler PF Hertel J Hackermuller J Hofacker IL Bell I Cheung E Drenkow J Dumais E Patel S Helt G Ganesh M Ghosh S Piccolboni A Sementchenko V Tammana H Gingeras TR RNA maps reveal new RNA classes and a possible function for pervasive transcription Science 2007 316 1484 1488 17510325
  143. [144]Pennisi E Genomics: DNA study forces rethink of what it means to be a gene Science 2007 316 1556 1557 17569836
  144. [145]Amaral PP Dinger ME Mercer TR Mattick JS The eukaryotic genome as an rna machine Science 2008 319 1787 1789 18369136
  145. [146]Ambros V The evolution of our thinking about microRNAs Nat. Med 2008 14 1036 1040 18841144
  146. [147]Ruvkun G The perfect storm of tiny rnas Nat. Med 2008 14 1041 1045 18841145
  147. [148]Baulcombe DC Short silencing RNA: The dark matter of genetics? Cold Spring Harb. Symp. Quant. Biol 2006 71 13 20 17381275
  148. [149]Saini HK Griffiths-Jones S Enright AJ Genomic analysis of human microRNA transcripts Proc. Natl. Acad. Sci 2007 104 17719 17724 17965236 PMC2077053
  149. [150]Verghese ET Hanby AM Speirs V Hughes TA Small is beautiful: microRNAs and breast cancer-where are we now? J. Pathol 2008 215 214 221 18446835
  150. [151]Thomson JM Newman M Parker JS Morin-Kensicki EM Wright T Hammond SM Extensive post-transcriptional regulation of microRNAs and its implications for cancer Genes Dev 2006 20 2202 2207 16882971 PMC1553203
  151. [152]Hock J Meister G The argonaute protein family Genome Biol 2008 9 210 18304383 PMC2374724
  152. [153]Pasquinelli AE Hunter S Bracht J MicroRNAs: a developing story Curr. Opin. Genet. Dev 2005 15 200 205 15797203
  153. [154]Sen GL Blau HM A brief history of rnai: the silence of the genes FASEB J 2006 20 1293 1299 16816104
  154. [155]Berkhout B Jeang K-T Riscy business: MicroRNAs, pathogenesis, and viruses J. Biol. Chem 2007 282 26641 26645 17627941
  155. [156]Cuellar TL McManus MT MicroRNAs and endocrine biology J. Endocrinol 2005 187 327 332 16423811
  156. [157]Chendrimada TP Finn KJ Ji X Baillat D Gregory RI Liebhaber SA Pasquinelli AE Shiekhattar R MicroRNA silencing through risc recruitment of eif6 Nature 2007 447 823 828 17507929
  157. [158]Perron MP Provost P Protein interactions and complexes in human microRNA biogenesis and function Front. Biosci 2008 13 2537 2547 17981733 PMC2901379
  158. [160]Vasudevan S Tong Y Steitz JA Switching from repression to activation: microRNAs can up-regulate translation Science 2007 318 1931 1934 18048652
  159. [161]Tsuchiya Y Nakajima M Takagi S Taniya T Yokoi T MicroRNA regulates the expression of human cytochrome p450 1b1 Cancer Res 2006 66 9090 9098 16982751
  160. [162]Adams BD Furneaux H White BA The micro-ribonucleic acid (mirna) mir-206 targets the human estrogen receptor-{alpha} (er{alpha}) and represses er{alpha} messenger rna and protein expression in breast cancer cell lines Mol. Endocrinol 2007 21 1132 1147 17312270
  161. [163]Corney DC Flesken-Nikitin A Godwin AK Wang W Nikitin AY MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth Cancer Res 2007 67 8433 8438 17823410
  162. [164]Gaur A Jewell DA Liang Y Ridzon D Moore JH Chen C Ambros VR Israel MA Characterization of microRNA expression levels and their biological correlates in human cancer cell lines Cancer Res 2007 67 2456 2468 17363563
  163. [165]Gramantieri L Ferracin M Fornari F Veronese A Sabbioni S Liu C-G Calin GA Giovannini C Ferrazzi E Grazi GL Croce CM Bolondi L Negrini M Cyclin g1 is a target of mir-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Res 2007 67 6092 6099 17616664
  164. [166]Hurteau GJ Carlson JA Spivack SD Brock GJ Overexpression of the microRNA hsa-mir-200c leads to reduced expression of transcription factor 8 and increased expression of e-cadherin Cancer Res 2007 67 7972 7976 17804704
  165. [167]Johnson CD Esquela-Kerscher A Stefani G Byrom M Kelnar K Ovcharenko D Wilson M Wang X Shelton J Shingara J Chin L Brown D Slack FJ The let-7 microRNA represses cell proliferation pathways in human cells Cancer Res 2007 67 7713 7722 17699775
  166. [168]Lujambio A Ropero S Ballestar E Fraga MF Cerrato C Setien F Casado S Suarez-Gauthier A Sanchez-Cespedes M Gitt A Spiteri I Das PP Caldas C Miska E Esteller M Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res 2007 67 1424 1429 17308079
  167. [169]Meng F Henson R Wehbe-Janek H Ghoshal K Jacob ST Patel T MicroRNA-21 regulates expression of the pten tumor suppressor gene in human hepatocellular cancer Gastroenterology 2007 133 647 658 17681183 PMC4285346
  168. [170]Osada H Takahashi T MicroRNAs in biological processes and carcinogenesis Carcinogenesis 2007 28 2 12 17028302
  169. [171]Sampson VB Rong NH Han J Yang Q Aris V Soteropoulos P Petrelli NJ Dunn SP Krueger LJ MicroRNA let-7a down-regulates myc and reverts myc-induced growth in burkitt lymphoma cells Cancer Res 2007 67 9762 9770 17942906
  170. [172]Sylvestre Y De Guire V Querido E Mukhopadhyay UK Bourdeau V Major F Ferbeyre G Chartrand P An e2f/mir-20a autoregulatory feedback loop J. Biol. Chem 2007 282 2135 2143 17135249
  171. [173]Thai T-H Calado DP Casola S Ansel KM Xiao C Xue Y Murphy A Frendewey D Valenzuela D Kutok JL Schmidt-Supprian M Rajewsky N Yancopoulos G Rao A Rajewsky K Regulation of the germinal center response by microRNA-155 Science 2007 316 604 608 17463289
  172. [174]Woods K Thomson JM Hammond SM Direct regulation of an oncogenic micro-rna cluster by e2f transcription factors J. Biol. Chem 2007 282 2130 2134 17135268
  173. [175]Zhang W Dahlberg JE Tam W MicroRNAs in tumorigenesis: a primer Am. J. Pathol 2007 171 728 738 17724137 PMC1959494
  174. [176]Zhou Y Yau C Gray JW Chew K Dairkee SH Moore DH Eppenberger U Eppenberger-Castori S Benz CC Enhanced nf kappa b and ap-1 transcriptional activity associated with antiestrogen resistant breast cancer BMC Cancer 2007 7 59 17407600 PMC1852565
  175. [177]Volinia S Calin GA Liu C-G Ambs S Cimmino A Petrocca F Visone R Iorio M Roldo C Ferracin M Prueitt RL Yanaihara N Lanza G Scarpa A Vecchione A Negrini M Harris CC Croce CM A microRNA expression signature of human solid tumors defines cancer gene targets Proc. Natl. Acad. Sci. USA 2006 103 2257 2261 16461460 PMC1413718
  176. [178]Zhang L Huang J Yang N Greshock J Megraw MS Giannakakis A Liang S Naylor TL Barchetti A Ward MR Yao G Medina A O'Brien-Jenkins A Katsaros D Hat-zigeorgiou A Gimotty PA Weber BL Coukos G MicroRNAs exhibit high frequency genomic alterations in human cancer Proc. Natl. Acad. Sci. USA 2006 103 9136 9141 16754881 PMC1474008
  177. [179]Henderson BE Feigelson HS Hormonal carcinogenesis Carcinogenesis 2000 21 427 433 10688862
  178. [180]Russo J Tahin Q Lareef MH Hu YF Russo IH Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens Environ. Mol. Mutagen 2002 39 254 263 11921196
  179. [181]Russo J Lareef MH Tahin Q Hu YF Slater C Ao X Russo IH 17beta-estradiol is carcinogenic in human breast epithelial cells J. Steroid Biochem. Mol. Biol 2002 80 149 162 11897500
  180. [182]Russo J Fernandez SV Russo PA Fernbaugh R Sheriff FS Lareef HM Garber J Russo IH 17-beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells FASEB J 2006 20 1622 1634 16873885
  181. [183]Wiseman RA Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly J. Clin. Epidemiol 2004 57 766 772 15485727
  182. [184]Chan JA Krichevsky AM Kosik KS MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells Cancer Res 2005 65 6029 6033 16024602
  183. [185]Hammond SM MicroRNAs as oncogenes Curr. Opin. Genet. Dev 2005 16361094
  184. [186]Hayashita Y Osada H Tatematsu Y Yamada H Yanagisawa K Tomida S Yatabe Y Kawahara K Sekido Y Takahashi T A polycistronic microRNA cluster, mir-17-92, is overexpressed in human lung cancers and enhances cell proliferation Cancer Res 2005 65 9628 9632 16266980
  185. [187]Johnson SM Grosshans H Shingara J Byrom M Jarvis R Cheng A Labourier E Reinert KL Brown D Slack FJ Ras is regulated by the let-7 microRNA family Cell 2005 120 635 647 15766527
  186. [188]Diederichs S Haber DA Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing Cancer Res 2006 66 6097 6104 16778182
  187. [189]Scott GK Mattie MD Berger CE Benz SC Benz CC Rapid alteration of microRNA levels by histone deacetylase inhibition Cancer Res 2006 66 1277 1281 16452179
  188. [190]Giannakakis A Coukos G Hatzigeorgiou A Sandaltzopoulos R Zhang L miRNA genetic alterations in human cancers Expert Opin. Biol. Ther 2007 7 1375 1386 17727327
  189. [191]Sempere LF Christensen M Silahtaroglu A Bak M Heath CV Schwartz G Wells W Kauppinen S Cole CN Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer Cancer Res 2007 67 11612 11620 18089790
  190. [192]Gusev Y Schmittgen TD Lerner M Postier R Brackett D Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer BMC Bioinformatics 2007 8 Suppl 7 S16 18047715 PMC2099484
  191. [193]Lu Z Liu M Stribinskis V Klinge CM Ramos KS Colburn NH Li Y MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene Oncogene 2008 27 4373 4379 18372920 PMC11968769
  192. [194]Hossain A Kuo MT Saunders GF Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of aib1 mRNA Mol. Cell. Biol 2006 26 8191 8201 16940181 PMC1636750
  193. [195]Scott GK Goga A Bhaumik D Berger CE Sullivan CS Benz CC Coordinate suppression of erbb2 and erbb3 by enforced expression of micro-RNA mir-125a or mir-125b J. Biol. Chem 2007 282 1479 1486 17110380
  194. [196]Creighton CJ Nagaraja AK Hanash SM Matzuk MM Gunaratne PH A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions RNA 2008 14 2290 2296 18812437 PMC2578856
  195. [197]Cohen A Shmoish M Levi L Cheruti U Levavi-Sivan B Lubzens E Alterations in micro-ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation Endocrinology 2008 149 1687 1696 18096665
  196. [198]Kovalchuk O Tryndyak VP Montgomery B Boyko A Kutanzi K Zemp F Warbritton AR Latendresse JR Kovalchuk I Beland FA Pogribny IP Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression Cell Cycle 2007 6 2010 2018 17700064
  197. [199]Dai R Phillips RA Zhang Y Khan D Crasta O Ahmed SA Suppression of lps-induced ifn{gamma} and nitric oxide in splenic lymphocytes by select estrogen-regulated mirna: a novel mechanism of immune modulation Blood 2008 112 12 4591 4597 18791161 PMC2597130
  198. [200]Hong X Luense LJ McGinnis LK Nothnick WB Christen-son LK Dicer1 is essential for female fertility and normal development of the female reproductive system Endocrinology 2008 149 12 6207 6212 18703631 PMC2613048
  199. [201]Carletti MZ Christenson LK MicroRNA in the ovary and female reproductive tract J. Anim Sci 2008 18791135 PMC3118666
  200. [202]Hu S-J Ren G Liu J-L Zhao Z-A Yu Y-S Su R-W Ma X-H Ni H Lei W Yang Z-M MicroRNA expression and regulation in mouse uterus during embryo implantation J. Biol. Chem 2008 283 23473 23484 18556655

200 of 228 shown

Cited by

Sorted by citations

Authors
Klinge, C.
Venue
Current Genomics
Publisher
Bentham Science Publishers Ltd.
Published
2009-05-01
Volume
10
Issue
3
Pages
169-183
ISSN
1389-2029
DOI
10.2174/138920209788185289
PMC
PMC2705850
Cited by
138
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review